GSK and 23andMe sign agreement to leverage genetic insights for the development of novel medicines Read more
Athenex Announces That Two Phase 3 Pivotal Efficacy Studies of KX2-391 in Actinic Keratosis Achieved Their Primary Endpoints Read more
Bristol-Myers Squibb, Sandoz, AmerisourceBergen, Genetech and more joining the LogiPharma 2018 Conference Read more
Convelo Therapeutics to Develop New Regenerative Medicines for Neurological Disease Characterized by Loss of Myelin Read more